Home » Catalent News » The Effect Of Pipeline Success On Clinical Trial Supplies To Be Presented By Catalent At SCOPE Summit

The Effect Of Pipeline Success On Clinical Trial Supplies To Be Presented By Catalent At SCOPE Summit

SOMERSET, N.J. – February 12, 2019 — Catalent Pharma Solutions, a global leader in clinical supply services, today announced that Eva Allen, Senior Clinical Supplies Manager, will present at the upcoming 10th Annual SCOPE Summit for Clinical Ops Executives at the Hyatt Regency Orlando Hotel, Orlando, Florida, on Feb. 18-21, 2019.

In her presentation, “Turning Up the Heat: The Effect of Pipeline Success on Clinical Supplies” on Tuesday, Feb. 19 at 3:40 p.m., Ms. Allen will discuss the ways in which clinical supply strategy and execution change as sponsors progress into later phase trials. Her presentation will explore the aspects of clinical supply that sponsors find most challenging, and the primary concerns associated with outsourcing clinical supplies. She will also discuss clinical supply considerations for studies conducted outside of North America.

In her role at Catalent, Ms. Allen is responsible for end-to-end clinical supply strategy, forecasting, and support, including interactive response technology (IRT) set up and inventory management. She has 18 years’ experience in the pharmaceutical industry, focusing on commercial and clinical manufacturing supplies management. Ms. Allen holds a bachelor’s degree in industrial distribution and logistics from East Carolina University.

For more information visit this page.

To arrange a meeting with Ms. Allen at the conference, contact Ed Dutton at NEPR – edward@nepr.eu  

Media Contacts:

Chris Halling
+44 (0)7580 041073
chris.halling@catalent.com

Richard Kerns
+44 (0) 161 728 5880
richard@nepr.eu

ABOUT CATALENT

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.

 

More products. Better treatments. Reliably supplied.™